glp-1 lilly Novo, weight-loss drugs should be first option obesity treatments, European doctors say As GLP-1 Use Expands, Long-Term

Although some studies have demonstrated benefits such as increased lean body mass and improved body composition (in populations with clinical need for the drugs), these gains have not consistently translated into enhancements in muscle strength, physical performance, or overall quality of life

Typically occurring between ages 45 and 55, perimenopause transition is characterized by fluctuating estrogen levels and declining ovarian function that initiate a cascade of physiological and psychological changes that extend far beyond reproductive health

This is also why Melanotan II shows up in sexual forums

It's not something to be approached lightly

Kidouchi, N

10.3390/plants12010005 116 ImamS